This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: American Type Culture Collection, Mannkind Corporation. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Zhidong Xie: Innovator in Peptide Analogues and Diabetes Treatment
Introduction
Zhidong Xie is a notable inventor based in Manassas, Virginia, recognized for his contributions to the fields of immunology and diabetes research. With a total of two patents to his name, Xie's work focuses on the development of peptide analogs and methods for treating type 2 diabetes. His innovative approaches have the potential to significantly impact therapeutic strategies in these areas.
Latest Patents
Xie's latest patents include advancements in SSX-2 peptide analogs. These embodiments relate to analogs of peptides corresponding to class I MHC-restricted T cell epitopes and methods for their generation. The analogs can contain amino acid substitutions at residues that directly interact with MHC molecules, conferring improved, modified, or useful immunologic properties. Additionally, classes of analogs are disclosed, where various substitutions comprise the non-standard residues norleucine and/or norvaline. Another significant patent pertains to methods for the treatment of type 2 diabetes. This invention relates to the identification of biological markers associated with an increased risk of developing diabetes, as well as methods of using such markers in diagnosis and prognosis. The biological markers may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of diabetes.
Career Highlights
Throughout his career, Zhidong Xie has worked with reputable organizations, including the American Type Culture Collection and Mannkind Corporation. His experience in these companies has allowed him to refine his expertise in biotechnology and therapeutic development.
Collaborations
Xie has collaborated with notable colleagues, including Liping Liu and Cohava Gelber. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Zhidong Xie's innovative work in peptide analogs and diabetes treatment showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile